Neutropenic enterocolitis in a patient with ovarian cancer after treatment with high-dose carboplatin and granulocyte macrophage-colony stimulating factor (GM-CSF).

Abstract	A 50-yr-old women is described with relapsed ovarian cancer. She developed neutropenic enterocolitis after treatment with high-dose carboplatin (1000 mg/m2) and granulocyte macrophage-colony stimulating factor (GM-CSF). The clinical features and the pathogenesis of neutropenic enterocolitis are discussed. This case is the first report of neutropenic enterocolitis associated with the treatment of carboplatin.
Authors	L T Vlasveld, W W Ten Bokkel Huinink, S Rodenhuis
Journal	The Netherlands journal of medicine (Neth J Med) Vol. 37 Issue 3-4 Pg. 158-61 (Oct 1990) ISSN: 0300-2977 [Print] Netherlands
PMID	2250761 (Publication Type: Case Reports, Journal Article)
Chemical References	Macrophage Colony-Stimulating Factor Carboplatin
Topics	Antineoplastic Combined Chemotherapy Protocols (adverse effects) Carboplatin (administration & dosage) Combined Modality Therapy Enterocolitis (chemically induced) Female Humans Macrophage Colony-Stimulating Factor (administration & dosage) Middle Aged Neutropenia (chemically induced) Ovarian Neoplasms (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!